Management of Respiratory Conditions with Prednisone and Symbicort

Introduction to Combined Therapy

The American College of Physicians recommends that patients can take prednisone and Symbicort together during acute exacerbations of respiratory conditions, but this combination requires careful monitoring and should be time-limited to minimize cumulative corticosteroid effects 1

For acute exacerbations not controlled with inhaled corticosteroids alone, adding systemic prednisone at 40-60 mg/day while continuing Symbicort is both appropriate and necessary to induce remission 1
Prednisone should be used for short-term therapy, typically 5-10 days for acute exacerbations, to minimize adverse effects 1
Evaluate patient response between 2-4 weeks to determine if therapy modifications are needed, as recommended by the American Thoracic Society 2, 1

The combination of oral and inhaled corticosteroids significantly increases the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression and adrenal insufficiency, according to the Endocrine Society 1
Do not abruptly discontinue prednisone after prolonged use (>2-3 weeks), as this can precipitate adrenal crisis, warns the American College of Endocrinology 1

Continue Symbicort at current maintenance dose and add prednisone 40-60 mg daily, scheduled in the morning to minimize sleep disturbances and align with natural cortisol rhythm, as suggested by the American Academy of Sleep Medicine 1
Evaluate symptomatic response to determine need for therapy modification, and if adequate response, begin prednisone taper, recommends the American College of Chest Physicians 2, 1

Corticosteroids, especially repeat courses, should be avoided or used with extreme caution in patients with poorly controlled diabetes, history of steroid-induced psychosis or depression, history of avascular necrosis, severe osteoporosis with or without pathologic fractures, or any other prior severe steroid side effect/toxicity, advises the American Diabetes Association 2